StonvexLoading…
StonvexStonvexStonvexCore line items from LH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.54B | $13.95B | $10.44B | $6.87B |
Operating Income | $380.80M | $1.38B | $1.12B | $720.50M |
Net Income | $277.80M | $876.50M | $711.80M | $237.90M |
EPS (Diluted) | $3.35 | $10.46 | $8.48 | $5.36 |
Total Assets | $19.09B | $18.39B | $18.26B | $18.06B |
Total Liabilities | $10.34B | $9.76B | $9.55B | $9.57B |
Cash & Equivalents | $981.10M | $532.30M | $598.10M | $647.30M |
Free Cash Flow OCF − CapEx | $70.50M | $1.21B | $715.70M | $435.20M |
Shares Outstanding | 82.30M | 82.20M | 83.00M | 82.90M |